'Russian boxer Povetkin's alternative doping tests clean'

Image
IANS Moscow
Last Updated : Feb 02 2017 | 4:32 PM IST

Russian boxer Aleksandr Povetkins alternative doping tests at a laboratory in Lausanne have yielded controversial results, World of Boxing promotion company Director Andrey Ryabinsky has said.

Ryabinsky said an independent examination of Povetkin's A and B urine samples were done and both the samples came out clean.

"We have the results of alternative tests from another laboratory, the one in Lausanne. The probe samples are clean," he said.

A probe of Povetkin's B sample urine recently tested positive for banned drug Ostarine, just as A sample did earlier. Both samples were taken by the Voluntary Anti-Doping Association (VADA) and opened at a laboratory in Los Angeles. After VADA announced the results of the tests Ryabinsky ensured another examination of Povetkin's samples in a Switzerland lab.

Ostarine, also known as MK-2866, or Enobosarm, is a Selective Androgen Receptor Module (SARM), used to avoid and treat muscle wasting. Just like anabolic steroids, it enhances endurance. SARM substances were outlawed by the World Anti-Doping Agency (WADA) in 2008.

The World Boxing Council refused to approve of a fight between Povetkin and Canada's Bermane Stiverne on December 6 after Povetkin's probe tested positive for Ostarine. However, samples taken on December 13 and 15 were negative.

Ryabinsky said it takes Ostarine more than 12 months to leave the human body, which is a reason enough to call in question the results of tests.

Also, Ryabinsky speculated that the outlawed substance might have been taken by Povetkin unknowingly together with daily meals or sports nutrition products.

--IANS

sam/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 02 2017 | 4:26 PM IST

Next Story